Product Description
Specification
- Packaging Size : 30
- Brand : Gefticip 250 Mg Tablets
- Composition : geftinib
- Manufacturer : Cipla
- Treatment : anti caner
- Prescription/Non prescription : Prescription
- Form : Tablet
Precise Dosage and AdministrationGefticip 250 mg Tablets are specially formulated as oral medication for adults diagnosed with non-small cell lung cancer. It is vital that patients follow the dosage and guidelines provided by their healthcare professional to ensure safety and effectiveness. Each dose is carefully calibrated to address the specific needs of individuals undergoing cancer therapy.
Proper Storage and HandlingTo maintain the efficacy of Gefticip 250 mg Tablets, store them in a cool, dry place away from moisture and direct sunlight. Do not use the medicine beyond its expiry date, which is indicated as per batch details. Handling the blister pack with clean hands helps preserve the integrity of the medication over its 24-month shelf life.
Patient Safety and Side EffectsWhile Gefticip provides significant therapeutic benefits for NSCLC patients, some individuals may experience side effects such as rash, diarrhea, or nausea. Patients are encouraged to promptly inform their physician about any adverse reactions. Continuous monitoring by a healthcare provider ensures the safest and most effective treatment experience.
FAQ's of Gefticip 250 Mg Tablets:
Q: How should Gefticip 250 mg Tablets be taken for best results?
A: Gefticip 250 mg Tablets should be taken orally exactly as directed by your physician, without altering the dosage. Consistency and compliance with the prescribed schedule optimize treatment outcomes.
Q: What are the key benefits of using Gefticip 250 mg Tablets?
A: Gefticip is specifically designed for adults with non-small cell lung cancer, helping to inhibit cancer cell growth and potentially improve disease management when used as prescribed.
Q: When is it recommended to start Gefticip 250 mg Tablets?
A: Your physician will determine the appropriate time to begin Gefticip therapy based on your diagnosis and treatment plan for non-small cell lung cancer.
Q: Where should I store Gefticip 250 mg Tablets?
A: Keep the tablets in a dry, cool place, away from moisture and heat. Always store them in their original blister pack until use, following the instructions provided.
Q: What side effects might I experience with Gefticip 250 mg Tablets?
A: Some common side effects include rash, diarrhea, and nausea. If you experience any severe or persistent symptoms, consult your physician promptly.
Q: How is the expiry of Gefticip 250 mg Tablets determined?
A: The expiry date is specific to each batch and is clearly mentioned on the packaging. Do not use the medicine beyond this date to ensure its effectiveness and safety.
Q: Who can use Gefticip 250 mg Tablets?
A: Gefticip is suitable for adult patients diagnosed with non-small cell lung cancer and should only be used under medical supervision, as it requires a prescription.